SAI
DNLI icon

Savvy Advisors Inc’s Denali Therapeutics DNLI Stock Holding History

Savvy Advisors Inc’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
+45,194
New +$929K 0.02% 478
2026
Q1 		– Sell
-39,030
Closed -$644K – 1155
2025
Q4 		$644K Sell
39,030
-38,063
-49% -$642K 0.02% 483
2025
Q3 		$1.12M Sell
77,093
-20,700
-21% -$297K 0.05% 247
2025
Q2 		$1.37M Buy
+97,793
New +$1.38M 0.09% 161

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Savvy Advisors Inc's DNLI Position: Q2 2026 in Review

Savvy Advisors Inc opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 45,194 shares worth $1.16M. The stake represents 0.02% of the portfolio and ranks #478 among its holdings. This is a return to the name: Savvy Advisors Inc previously reported a position in DNLI as recently as Q4 2025.

Savvy Advisors Inc first reported a position in DNLI in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.37M in Q2 2025. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Savvy Advisors Inc held 45,194 shares of Denali Therapeutics worth $1.16M as of Q2 2026.
  • Denali Therapeutics was a new Savvy Advisors Inc position in Q2 2026.
  • Denali Therapeutics made up 0.02% of Savvy Advisors Inc's portfolio in Q2 2026, its #478 holding.
  • Savvy Advisors Inc first reported a position in Denali Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Savvy Advisors Inc's Denali Therapeutics position peaked at $1.37M in Q2 2025.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.